A study of organic acid transporter-mediated pharmacokinetic interaction between NXY-059 and cefuroxime

Journal of Clinical Pharmacology

Volumn 47, Issue 8, 2007, Pages 1043-1048

  Kågedal, Matts ^a   Nilsson, Dag ^a   Huledal, Gunilla ^a   Reinholdsson, Ingalill ^b   Cheng, Yi Fang ^c   Åsenblad, Nils ^a   Pekar, David ^d   Borgå, Olof ^e  

^a ASTRAZENECA R AND D   (Sweden)

^b Clinical Development   (Sweden)

^c Clinical Pharmacology   (Sweden)

^d IQVIA   (United States)

^e Borgå PK Consulting ^*  (Sweden)

Author keywords

Cefuroxime; NXY 059; Organic acid transporter; Pharmacokinetics

Indexed keywords

CARRIER PROTEIN; CEFUROXIME; DISUFENTON SODIUM; ORGANIC ACID TRANSPORTER; UNCLASSIFIED DRUG;

ACTIVE TRANSPORT; ADULT; ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG URINE LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; KIDNEY CLEARANCE; LOADING DRUG DOSE; MALE; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT;

EID: 34447639743     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270007303769     Document Type: Article

References (7)

1. Edenius C., Strid S., Borgå O., Breitholtz-Emanuelsson A., Vallen KL, Fransson B. Pharmacokinetics of NXY-059, a nitrone-based free radical trapping agent, in healthy young and elderly subjects. J Stroke Cerebrovasc Dis. 2002 ; 11: 34-43.
2. Cheng Y-F., Strid S., Borgå O., Nilsson D., Wemer J. Effects of cimetidine and probenecid on renal clearance of NXY-059, a novel neuroprotectant: a phase I study to determine the transporter responsible for active secretion. Clin Pharmacol Ther. 2006 ; 79: 72.
3. Wemer J., Cheng Y-F., Nilsson D., et al. Safety, tolerability and pharmacokinetics of escalating doses of NXY-059 in healthy young and elderly subjects. Curr Med Res Opin. 2006 ; 22: 1813-1823.
4. Gower PE, Dash CH The pharmacokinetics of cefuroxime after intravenous injection. Eur J Clin Pharmacol. 1977 ; 12: 221-227.
5. Cockcroft DW, Gault MH Prediction of creatinine clearance from serum creatinine. Nephron. 1976 ; 16: 31-41.
6. Zinacef in drug knowledge and disease information. In: PDR- Physicians' Desk Reference. GreenwoodVillage,Colo: Thomson Micromedex; 2006: 70.
7. Verhagen CA, Mattie H., Van Strijen E. The renal clearance of cefuroxime and ceftazidime and the effect of probenecid on their tubular excretion. Br J Clin Pharmacol. 1994 ; 37: 193-197.